Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADAP Adaptimmune Therapeutics plc

盘后交易 07-23 19:05:11 EDT

1.23

+0.02

+1.65%

盘后1.26

+0.03+2.44%

18:36 EDT

最高1.27	最低1.21	成交量129.40万
今开1.21	昨收1.21	日振幅4.96%
总市值3.14亿	流通市值2.10亿	总股本2.56亿
成交额160.12万	换手率0.76%	流通股本1.70亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADAP","market":"US","secType":"STK","nameCN":"Adaptimmune Therapeutics plc","latestPrice":1.23,"timestamp":1721764800000,"preClose":1.21,"halted":0,"volume":1294013,"hourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.23,"latestTime":"18:36 EDT","volume":18063,"amount":22749.958339200002,"timestamp":1721774214001},"delay":0,"floatShares":170366202,"shares":255561979,"eps":-0.741975,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.02,"latestTime":"07-23 19:05:11 EDT","open":1.21,"high":1.27,"low":1.21,"amount":1601246.4951497,"amplitude":0.049587,"askPrice":1.27,"askSize":1000,"bidPrice":1.21,"bidSize":6700,"shortable":3,"etf":0,"ttmEps":-0.741975,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721779200000},"adr":1,"listingDate":1430884800000,"adjPreClose":1.21,"adrRate":6,"preHourTrading":{"tag":"盘前","latestPrice":1.2388,"preClose":1.21,"latestTime":"09:20 EDT","volume":13256,"amount":16360.3152664,"timestamp":1721740852662},"postHourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.23,"latestTime":"18:36 EDT","volume":18063,"amount":22749.958339200002,"timestamp":1721774214001},"volumeRatio":1.021021,"impliedVol":0.9038,"impliedVolPercentile":0.1389},"requestUrl":"/m/hq/s/ADAP/wiki","defaultTab":"wiki","newsList":[{"id":"2453798517","title":"Adaptimmune Therapeutics Plc盘中异动 股价大涨6.84%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453798517","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453798517?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:31","pubTimestamp":1721655079,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时31分，Adaptimmune Therapeutics Plc股票出现波动，股价急速拉升6.84%。截至发稿，该股报1.25美元/股，成交量1.6067万股，换手率0.01%，振幅0.00%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Mei Pharma, Inc.、Cellectar Biosciences, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为92.28%、76.82%、15.14%，振幅较大的相关个股有Exicure, Inc.、Dbv Technologies、Inmune Bio Inc.，振幅分别为11.83%、8.21%、7.80%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222131199681ee2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222131199681ee2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0},{"id":"2452143317","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452143317","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452143317?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:12","pubTimestamp":1721315549,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时12分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅下挫5.56%。截至发稿，该股报1.19美元/股，成交量59.9448万股，换手率0.23%，振幅6.35%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为1.08%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Silo Pharma, Inc.、Onconetix, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为2086.86%、1119.34%、370.18%，振幅较大的相关个股有Silo Pharma, Inc.、Onconetix, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ，振幅分别为93.33%、86.24%、65.64%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718231230aefa59c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718231230aefa59c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0},{"id":"2451628465","title":"Adaptimmune Therapeutics Plc盘中异动 急速上涨5.47%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451628465","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451628465?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:37","pubTimestamp":1721050668,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时37分，Adaptimmune Therapeutics Plc股票出现异动，股价快速拉升5.47%。截至发稿，该股报1.35美元/股，成交量31.5823万股，换手率0.12%，振幅4.69%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Aeon Biopharma, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Solid Biosciences Inc.涨幅较大，Artelo Biosciences, Inc.、Qualigen Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为95.36%、52.16%、23.72%，振幅较大的相关个股有Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为18.40%、18.21%、12.78%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213748941f70d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213748941f70d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2450531822","title":"Adaptimmune Therapeutics Plc盘中异动 快速上涨5.24%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450531822","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450531822?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:18","pubTimestamp":1720793915,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时18分，Adaptimmune Therapeutics Plc股票出现异动，股价快速拉升5.24%。截至发稿，该股报1.31美元/股，成交量44.4033万股，换手率0.17%，振幅6.52%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.47%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221835aef97c46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221835aef97c46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","LENZ","BK4139"],"gpt_icon":0},{"id":"2450005363","title":"Adaptimmune Therapeutics Plc盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450005363","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450005363?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:55","pubTimestamp":1720706129,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时55分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅拉升5.04%。截至发稿，该股报1.25美元/股，成交量27.9946万股，换手率0.11%，振幅1.68%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc、Terns Pharmaceuticals, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为484.03%、341.80%、273.02%，振幅较大的相关个股有Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为82.31%、73.13%、39.71%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112155299681c043&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112155299681c043&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0},{"id":"2450006977","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450006977","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450006977?lang=zh_cn&edition=full","pubTime":"2024-07-09 00:08","pubTimestamp":1720454880,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日00时08分，Adaptimmune Therapeutics Plc股票出现异动，股价急速下挫5.73%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Virpax Pharmaceuticals, Inc.、Morphic Holding, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为4561.06%、192.58%、167.85%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Fortress Biotech Inc 9.375% Cum Red Per Pref Ser A Usd25.00、Annovis Bio, Inc.，振幅分别为121.11%、50.07%、46.22%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090008019681ab1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090008019681ab1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAP","LENZ"],"gpt_icon":0},{"id":"2449298540","title":"Adaptimmune Therapeutics Plc盘中异动 早盘大幅拉升5.88%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449298540","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449298540?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:46","pubTimestamp":1720187168,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时46分，Adaptimmune Therapeutics Plc股票出现异动，股价急速上涨5.88%。截至发稿，该股报1.08美元/股，成交量20.0708万股，换手率0.08%，振幅4.90%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Qualigen Therapeutics, Inc.、Mediwound Ltd.涨幅较大，Qualigen Therapeutics, Inc.、Kintara Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1082.22%、682.87%、34.79%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为147.47%、39.09%、27.43%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705214608af90c9db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705214608af90c9db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0},{"id":"2448913844","title":"Adaptimmune Therapeutics Plc盘中异动 快速上涨5.24%报1.026美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448913844","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448913844?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:31","pubTimestamp":1719840672,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时31分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅拉升5.24%。截至发稿，该股报1.026美元/股，成交量2.139万股，换手率0.01%，振幅0.00%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.05%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213112aef76d25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213112aef76d25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ADAP"],"gpt_icon":0},{"id":"2446683623","title":"Adaptimmune Therapeutics Plc盘中异动 早盘急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446683623","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446683623?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:46","pubTimestamp":1719582380,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时46分，Adaptimmune Therapeutics Plc股票出现异动，股价快速上涨5.02%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、180 Life Sciences Corp C/Wts 07/11/2025、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Clearmind Medicine Inc.、Geovax Labs, Inc.、Carisma Therapeutics, Inc.较为活跃，换手率分别为344.41%、265.26%、28.00%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Geovax Labs Inc C/Wts 29/09/2025、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为92.60%、45.53%、42.93%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214621aef72997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214621aef72997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","LENZ","BK4139"],"gpt_icon":0},{"id":"2446559055","title":"Adaptimmune Therapeutics Plc盘中异动 早盘大幅上涨5.11%报0.874美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446559055","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446559055?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:37","pubTimestamp":1719499042,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时37分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅拉升5.11%。截至发稿，该股报0.874美元/股，成交量32.721万股，换手率0.13%，振幅4.16%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1738.98%、263.29%、246.31%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.，振幅分别为294.39%、127.05%、81.43%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627223722941f1d66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627223722941f1d66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAP","LENZ"],"gpt_icon":0},{"id":"2444190319","title":"Adaptimmune Therapeutics Plc盘中异动 下午盘股价大跌5.16%报0.958美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444190319","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444190319?lang=zh_cn&edition=full","pubTime":"2024-06-18 01:33","pubTimestamp":1718645595,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日01时33分，Adaptimmune Therapeutics Plc股票出现波动，股价快速下跌5.16%。截至发稿，该股报0.958美元/股，成交量97.1068万股，换手率0.38%，振幅5.94%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Biocardia Inc C/Wts 06/08/2024涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为4922.31%、2719.90%、175.35%，振幅较大的相关个股有Mustang Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Scinai Immunotherapeutics Ltd，振幅分别为276.85%、79.35%、53.30%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061801331596814adb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061801331596814adb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0},{"id":"2440111224","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440111224","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440111224?lang=zh_cn&edition=full","pubTime":"2024-06-04 02:55","pubTimestamp":1717440907,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日02时55分，Adaptimmune Therapeutics Plc股票出现异动，股价快速下挫5.31%。截至发稿，该股报1.07美元/股，成交量177.104万股，换手率0.69%，振幅7.08%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Biocardia Inc C/Wts 06/08/2024、Affimed N.V.涨幅较大，Bio-Path Holdings, Inc.、Affimed N.V.、Scorpius Holdings, Inc.较为活跃，换手率分别为3325.48%、184.56%、120.13%，振幅较大的相关个股有Exicure, Inc.、Affimed N.V.、Bio-Path Holdings, Inc.，振幅分别为97.73%、95.17%、86.41%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604025508941ebf7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604025508941ebf7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2439699258","title":"Adaptimmune Therapeutics Plc股价上涨14.36% 市值涨4238.7万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439699258","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439699258?lang=zh_cn&edition=full","pubTime":"2024-05-31 21:31","pubTimestamp":1717162318,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日21时31分，Adaptimmune Therapeutics Plc股票出现波动，股价快速拉升14.36%。截至发稿，该股报1.16美元/股，成交量590.474万股，换手率2.31%，振幅0.99%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.41%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213158957fd5b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213158957fd5b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2439647438","title":"Adaptimmune Therapeutics Plc盘中异动 早盘快速上涨5.94%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439647438","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439647438?lang=zh_cn&edition=full","pubTime":"2024-05-30 21:32","pubTimestamp":1717075965,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日21时32分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅上涨5.94%。截至发稿，该股报1.07美元/股，成交量7.2297万股，换手率0.03%，振幅1.98%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Kintara Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Gain Therapeutics, Inc.涨幅较大，Kintara Therapeutics, Inc.、Mustang Bio, Inc.、Onconetix, Inc.较为活跃，换手率分别为32.30%、22.47%、17.08%，振幅较大的相关个股有Prelude Therapeutics Incorporated、Renovorx, Inc.、Entera Bio Ltd.，振幅分别为11.75%、9.76%、9.47%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213245aef28ff9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213245aef28ff9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAP","LENZ"],"gpt_icon":0},{"id":"2438063975","title":"Adaptimmune Therapeutics Plc盘中异动 股价大涨5.45%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438063975","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438063975?lang=zh_cn&edition=full","pubTime":"2024-05-25 01:11","pubTimestamp":1716570686,"startTime":"0","endTime":"0","summary":"北京时间2024年05月25日01时11分，Adaptimmune Therapeutics Plc股票出现异动，股价急速拉升5.45%。截至发稿，该股报1.07美元/股，成交量40.6293万股，换手率0.16%，振幅4.95%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Merus N.V.涨幅较大，Onconetix, Inc.、Verastem, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为142.74%、57.01%、34.56%，振幅较大的相关个股有Onconetix, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cns Pharmaceuticals, Inc.，振幅分别为104.53%、57.38%、52.04%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525011127aef19a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525011127aef19a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"gpt_icon":0},{"id":"2436980921","title":"Adaptimmune Therapeutics Plc2024财年第一财季实现净利润-48.48百万美元，同比减少4717.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436980921","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436980921?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:16","pubTimestamp":1716135390,"startTime":"0","endTime":"0","summary":"3月31日，Adaptimmune Therapeutics Plc公布财报，公告显示公司2024财年第一财季净利润为-48.48百万美元，同比减少4717.14%；其中营业收入为5.67百万美元，同比减少88.19%，每股基本收益为-0.20美元。从资产负债表来看，Adaptimmune Therapeutics Plc总负债2.34亿美元，其中短期债务5.25百万美元，资产负债比为1.11，流动比率为0.03。机构评级：截至2024年3月31日，当前有7家机构对Adaptimmune Therapeutics Plc目标价做出预测，其中目标均价为2.86美元，其中最低目标价为1.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520001641877abc57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520001641877abc57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP"],"gpt_icon":0},{"id":"2435185376","title":"Adaptimmune Therapeutics Plc盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435185376","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435185376?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:05","pubTimestamp":1715609122,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时05分，Adaptimmune Therapeutics Plc股票出现异动，股价快速拉升5.36%。截至发稿，该股报1.18美元/股，成交量3.9339万股，换手率0.02%，振幅5.87%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、Ac Immune Sa涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为50.93%、23.43%、18.89%，振幅较大的相关个股有Dbv Technologies、Tevogen Bio Holdings Inc.、Azitra Inc，振幅分别为36.84%、34.54%、29.77%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132205227a599be4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132205227a599be4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAP","LENZ"],"gpt_icon":0},{"id":"2434869784","title":"Adaptimmune Therapeutics Plc盘中异动 快速下跌5.26%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434869784","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434869784?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:21","pubTimestamp":1715358113,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日00时21分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅下跌5.26%。截至发稿，该股报1.08美元/股，成交量31.4007万股，换手率0.12%，振幅10.53%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.05%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100215379270a83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100215379270a83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ADAP"],"gpt_icon":0},{"id":"2433727158","title":"Adaptimmune Therapeutics Plc盘中异动 早盘大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433727158","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433727158?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:35","pubTimestamp":1715178944,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日22时35分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅下跌5.00%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Effector Therapeutics Inc C/Wts 31/12/2025 、Cel-Sci Corporation涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为230.93%、63.53%、25.91%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Chemomab Therapeutics Ltd，振幅分别为60.74%、43.00%、33.42%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082235447a58c54e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082235447a58c54e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2433728850","title":"Adaptimmune Therapeutics Plc盘中异动 下午盘股价大跌5.88%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433728850","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433728850?lang=zh_cn&edition=full","pubTime":"2024-05-07 01:26","pubTimestamp":1715016380,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日01时26分，Adaptimmune Therapeutics Plc股票出现波动，股价急速跳水5.88%。截至发稿，该股报1.12美元/股，成交量35.2829万股，换手率0.14%，振幅7.56%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nrx Pharmaceuticals, Inc.、Nanoviricides, Inc.涨幅较大，Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃，换手率分别为1226.25%、780.45%、151.86%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.，振幅分别为95.51%、90.41%、68.10%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507012620861eb3c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507012620861eb3c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adaptimmune.com","stockEarnings":[{"period":"1week","weight":-0.0281},{"period":"1month","weight":0.3596},{"period":"3month","weight":0.0614},{"period":"6month","weight":0.6923},{"period":"1year","weight":0.2857},{"period":"ytd","weight":0.5259}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adaptimmune Therapeutics Plc成立于2014年12月3日，是一家根据英格兰和威尔士法律注册成立的公众有限公司。该公司是一家临床阶段的生物制药公司，将于2024年过渡到商业阶段的细胞治疗公司。该公司专注于为癌症患者提供新型细胞疗法。公司第一个产品，afamitresgene autoleucel或“afami-cel”是滑膜肉瘤特有的，将是肉瘤产品专营的第一个产品。他们计划于2026年在美国商业推出的Lete-cel将是肉瘤专营权的第二个产品，将同时针对滑膜肉瘤和粘液样圆细胞脂肪肉瘤，显著扩大可治疗的患者群体。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.258042},{"month":2,"riseRate":0.333333,"avgChangeRate":0.016975},{"month":3,"riseRate":0.444444,"avgChangeRate":0.008185},{"month":4,"riseRate":0.666667,"avgChangeRate":0.067805},{"month":5,"riseRate":0.333333,"avgChangeRate":0.165831},{"month":6,"riseRate":0.3,"avgChangeRate":-0.040994},{"month":7,"riseRate":0.4,"avgChangeRate":-0.025106},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.018772},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.012303},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.214893},{"month":11,"riseRate":0.444444,"avgChangeRate":0.062997},{"month":12,"riseRate":0.444444,"avgChangeRate":0.034379}],"exchange":"NASDAQ","name":"Adaptimmune Therapeutics plc","nameEN":"Adaptimmune Therapeutics PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adaptimmune Therapeutics plc(ADAP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adaptimmune Therapeutics plc,ADAP,Adaptimmune Therapeutics plc股票,Adaptimmune Therapeutics plc股票老虎,Adaptimmune Therapeutics plc股票老虎国际,Adaptimmune Therapeutics plc行情,Adaptimmune Therapeutics plc股票行情,Adaptimmune Therapeutics plc股价,Adaptimmune Therapeutics plc股市,Adaptimmune Therapeutics plc股票价格,Adaptimmune Therapeutics plc股票交易,Adaptimmune Therapeutics plc股票购买,Adaptimmune Therapeutics plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adaptimmune Therapeutics plc(ADAP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}